ALGYL GGP
Preparation and activation
Optimisation of the intra-articular environment (HA viscosupplementation), activation of cartilage metabolism and support of proteoglycan synthesis.
ALGYL CBD · topical support
Moving again. Pain-free.
Non-invasive patch with CBD, arnica and menthol — local relief of muscle and joint pain, up to 24 h (avg. 21.7 h). 8 patches per pack.
8patches per pack
24 hup to this long-acting
21.7 haverage relief duration
OTCnon-invasive, over-the-counter
Composition
Three components, one patch, local action.
ALGYL CBD is a non-invasive topical patch with CBD, arnica and menthol. Suitable for pain and soreness from e.g. sports injuries or musculoskeletal conditions (e.g. arthritis).
Arnica
fluid extract
Plant extract complementing the product formulation.
Menthol
cooling counter-irritant
Produces a cooling sensation after patch application.
Cannabidiol (CBD)
purified isolate
Purified cannabidiol (CBD) isolate from Cannabis sativa.
Active ingredient (MDR): acrylic adhesive
Other ingredients: cannabidiol, menthol, arnica fluid extract
Form: transdermal patch
Suitable for vegans
How the patch works
Cooling sensation and continuous local application.
After the patch is applied, menthol produces a cooling sensation at the site. The thin, discreet patch allows non-invasive local application for up to 24 hours.
01
Immediate cooling
Menthol
Menthol produces a cooling sensation at the site of application.
02
Relief and calming
CBD + arnica
CBD isolate and arnica extract are released into the site of application beneath the patch.
03
Long-lasting action
up to 24 h
The patch is applied once daily, for a maximum of 24 hours.
Thin, flexible and discreet patch — local relief without injection.
Benefits and effects
Why physicians choose ALGYL CBD.
Long-lasting pain relief thanks to the continuous, consistent release of the components.
According to the available clinical summary, improvement in pain, mobility, stiffness and quality of life.
Convenient use — thin, flexible, adhesive patches in individual sachets. A discreet solution.
Discreet and flexible design for topical use, without the need for intra-articular administration.
Up to 24-hour pain relief — on average 21.7 hours.
Registered medical device, OTC — no medical prescription required.
Clinical efficacy
Clinical summary for ALGYL CBD.
According to the available clinical summary for the product.
Type of evidence: clinical summary (single-arm, 80 subjects; % of subjects with improvement). The full clinical context — design, population, methodology and endpoints — is set out in the clinical summary for the product.
Practical format
A non-invasive option for topical support.
ALGYL CBD is intended for patients who prefer a topical route of application in musculoskeletal discomfort. The patch may be a practical adjunct to topical care of the muscle and joint areas, in accordance with the current instructions for use.
8 patchesTopical formatDiscreet and flexible
Safety information
Read the IFU before use.
ALGYL CBD is intended for topical application to the skin in areas of muscle or joint discomfort. Complete information on the method of use, the maximum application time, restrictions of use, contraindications and safety warnings is provided in the current product data sheet and in the IFU.
Quality standards and use
Regulation and instructions for use.
Quality standards and regulation
The product is placed on the market in accordance with the European Medical Devices Regulation (EU 2017/745 — MDR). Quantitative clinical claims are bound to the clinical summary and the approved documentation.
Instructions for use
Application: Clean and dry the skin, remove the protective film and apply the patch to the painful area. Do not use on injured, irritated, infected or burnt skin. Do not cover with a bandage or a heat aid. After other products applied to the skin, rinse and wait at least 2 hours.
Dosage: 1× daily. The patch is intended for short-term use.
Sequential protocol
ALGYL CBD adds pain control to the sequence.
A professional proposal for a combined approach that respects the individual phases of joint tissue repair. The approximate interval between the main steps is 2–3 weeks.
ALGYL COLL
Structural support
Continued viscosupplementation and recombinant collagen as a structural component for regeneration of the extracellular matrix.
The scheme is a professional proposal for a combined approach, not a universal treatment algorithm.
View the whole scheme
Downloads and contact
ALGYL CBD documentation
For healthcare professionals
Would you like ALGYL CBD in your practice?
We will put you in touch with the inPHARM specialist representative for your region — with complete documentation and a tailored offer.
I’m interested — contact a representative